Deadline nears in Korean demand for class I device manufacturer QP
This article was originally published in Clinica
Manufacturers of Class I medical devices in South Korea are being asked by the Medical Devices Safety Bureau of the Korean Ministry of Food and Drug Safety (MFDS/KFDA) to appoint a quality management representative/qualified person (QP). They have until 29 July 2014 to fill these new posts, the holders of which will be charged with ensuring quality management by manufacturers and importers.
You may also be interested in...
The EU Partnership on Health Innovation, a new public private health care research partnership, is in the final drafting phase before its launch under Horizon Europe. In Vivo asked the partnership’s medtech industry lead, Patrick Boisseau, to set out the innovation challenges for participants as they address unmet health care needs in Europe.
Chinese monitoring of the spread of COVID-19 locally has reported no new cases of home-grown infection in a single day for the first time since the outbreak began. It indicates control efforts, including the NMPA’s fast-tracking of relevant devices, PPE and IVDs, are having the desired effects.
For its fifth annual Future Health Index, Royal Philips chose to focus on the insights and needs of health care professionals below the age of 40, a group that often feels unheard, and yet will form the basis of the workforce over the next two decades. Getting it right from their point of view is vital.